-The Hindu ALAPPUZHA: The United Nation's Food and Agriculture Organisation (FAO) formally declared the Kuttanad below sea-level farming system as Globally Important Agricultural Heritage Systems (GIAHS) at the International Forum on GIAHS held at Ishikawa Prefecture in japan from May 29 to June 1. Sources said agricultural scientist M.S. Swaminathan attended the conference, though an earlier decision was to send a delegation to the Forum. The government is expected to declare the...

-The Hindu New Delhi should stop its flip-flops and adopt a coherent policy in its negotiations on greenhouse gas emissions If the great Scott Fitzgerald were to have walked into the grand plenary hall of the Durban climate conference in 2011 to announce once again, "show me a hero and I will write you a tragedy," all fingers would have pointed to the tiny Indian contingent in the room. There, Fitzgerald would...

-Economic and Political Weekly   A report on the 2013 deliberation of the Kolkata Group at its 10th workshop which focused on healthcare, the status of women and social justice in India. A K Shiva Kumar (akshivakumar@gmail.com) is convener of the Kolkata Group workshops which are organised by Pratichi (India) Trust, the Harvard Global Equity Initiative and UNICEF India. At the 10th annual Kolkata Group workshop in February this year, 40 policymakers, development practitioners,...

-The Times of India A patch of wheat found growing in fallow field in Oregon, USA, has sent tremors across the world with some East Asian countries cancelling wheat import orders from the US, and the 27 member European Union to raise testing levels for US imports. The reason is that the wheat patch was found to be a genetically modified variety developed and tested by biotech giant Monsanto between 1999 and...

-The Business Standard USFDA's zero tolerance policy requires our drug firms to reorient not just processes but organisational cultures to serve that market credibly The following two quotes from the United States Food and Drug Administration (FDA) news releases may help put the Ranbaxy controversy in perspective. The first sums up what it is that drives the FDA and the second is typical of the challenge the pharmaceutical industry faces. (1) "The consent...